Picture of IRADIMED logo

IRMD — IRADIMED News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

IRadimed Corp reports results for the quarter ended in September - Earnings Summary

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted earnings
of 23 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was
for earnings of 17 cents per share.
* Revenue rose 41.7% to $10.91 million from a year ago; 
analysts expected $10.40 million. 
* IRadimed Corp's reported EPS for the quarter was 20 cents​.
* The mean earnings estimate of analysts had risen by
about 30.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* IRadimed Corp shares had risen by 7.8% this quarter and
gained 58.8% so far this year.
* The company reported quarterly net income of $2.58 million.
* Wall Street's median 12-month price target for IRadimed Corp
is $38.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated October 29 at 01:31 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on IRADIMED

See all news